A Secreted Soluble Form of ApoE Receptor 2 Acts As a Dominant-negative Receptor and Inhibits Reelin Signaling
Overview
Molecular Biology
Authors
Affiliations
Specialized neurons throughout the developing central nervous system secrete Reelin, which binds to ApoE receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR), triggering a signal cascade that guides neurons to their correct position. Binding of Reelin to ApoER2 and VLDLR induces phosphorylation of Dab1, which binds to the intracellular domains of both receptors. Due to differential splicing, several isoforms of ApoER2 differing in their ligand-binding and intracellular domains exist. One isoform harbors four binding repeats plus an adjacent short 13 amino acid insertion containing a furin cleavage site. It is not known whether furin processing of this ApoER2 variant actually takes place and, if so, whether the produced fragment is secreted. Here we demonstrate that cleavage of this ApoER2 variant does indeed take place, and that the resulting receptor fragment consisting of the entire ligand-binding domain is secreted as soluble polypeptide. This receptor fragment inhibits Reelin signaling in primary neurons, indicating that it can act in a dominant-negative fashion in the regulation of Reelin signaling during embryonic brain development.
Regulation of the hippocampal translatome by Apoer2-ICD release.
Wasser C, Werthmann G, Hall E, Kuhbandner K, Wong C, Durakoglugil M Mol Neurodegener. 2023; 18(1):62.
PMID: 37726747 PMC: 10510282. DOI: 10.1186/s13024-023-00652-1.
Apoer2-ICD-dependent regulation of hippocampal ribosome mRNA loading.
Wasser C, Werthmann G, Hall E, Kuhbandner K, Wong C, Durakoglugil M Res Sq. 2023; .
PMID: 37461529 PMC: 10350194. DOI: 10.21203/rs.3.rs-3040567/v1.
Lopez-Font I, Lennol M, Iborra-Lazaro G, Zetterberg H, Blennow K, Saez-Valero J Int J Mol Sci. 2022; 23(14).
PMID: 35886870 PMC: 9318932. DOI: 10.3390/ijms23147522.
Human APOER2 Isoforms Have Differential Cleavage Events and Synaptic Properties.
Omuro K, Gallo C, Scrandis L, Ho A, Beffert U J Neurosci. 2022; 42(20):4054-4068.
PMID: 35414534 PMC: 9121830. DOI: 10.1523/JNEUROSCI.1800-21.2022.
Gallo C, Labadorf A, Ho A, Beffert U Genomics. 2022; 114(2):110318.
PMID: 35192893 PMC: 8978334. DOI: 10.1016/j.ygeno.2022.110318.